Science Explorer Back to mapMap
Institution · TSC Alliance

Most cited papers from TSC Alliance

What are the most cited papers from TSC Alliance?

The most cited paper from TSC Alliance is "Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations" (Hope Northrup et al., 2021), with 750 citations. Next come "International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)" (61) and "The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review" (45).

Showing 28 of 28 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations Hope Northrup et al. · Pediatric Neurology Open access107 authors 24 Jul 2021 750
2 International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) Petrus J. de Vries et al. · Journal of Neurodevelopmental Disorders Open access 14 Sep 2023 61
3 The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review Stephanie Vanclooster et al. · Journal of Neurodevelopmental Disorders Open access 12 Feb 2022 45
4 Beyond the Guidelines: How We Can Improve Healthcare for People With Tuberous Sclerosis Complex Around the World Clare Stuart, Carla Fladrowski, Jennifer Flinn et al. · Pediatric Neurology Open access 26 Jul 2021 32
5 Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem) Tosca-Marie Heunis et al. · Frontiers in Psychiatry Open access 28 Feb 2022 24
6 Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ) Tosca-Marie Heunis et al. · Pediatric Neurology Open access 7 Jul 2023 21
7 Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database Sreedevi Boggarapu, Steven L. Roberds, JoAnne Nakagawa et al. · Orphanet Journal of Rare Diseases Open access 14 Sep 2022 16
8 Strategies for inclusive grantmaking Maryrose Franko, Sindy Escobar-Alvarez, Zoë Fuchs et al. · Nature Medicine Apr 2022 8
9 A Patient Perspective on Seizure Detection and Forecasting Aria Moss, Evan Moss, ROBERT E. MOSS et al. · Frontiers in Neurology Open access 11 Feb 2022 7
10 Epilepsy Community at an Inflection Point: Translating Research Toward Curing the Epilepsies and Improving Patient Outcomes Ilene Penn Miller, JayEtta Hecker, Brandy E. Fureman et al. · Epiliepsy currents/Epilepsy currents Open access 30 Jun 2021 7
11 Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ) Nola J. Chambers et al. · Orphanet Journal of Rare Diseases Open access 13 Jun 2025 5
12 Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death Shikshya Shrestha, Elio Adib, Jewel Imani et al. · Journal of Biological Chemistry Open access 8 Oct 2022 4
13 The role of the TSC Alliance in advancing therapy development: a patient organization perspective Steven L. Roberds, Zoë Fuchs, Elizabeth M. Cassidy et al. · Therapeutic Advances in Rare Disease Open access 2024 3
14 Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care Ashley J. Pounders, Gabrielle V. Rushing, Sonal Mahida et al. · Therapeutic Advances in Rare Disease Open access 2022 3
15 Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas Robert M. Vaughan, Jennifer J. Kordich, Chun-Yuan Chan et al. · Frontiers in Oncology Open access 10 Mar 2022 2
16 The small molecule simufilam dose‐dependently attenuates the worsening of seizures in a mouse model of tuberous sclerosis complex Branden J. Stansley, Md. Monirul Islam, Dean J. Aguiar et al. · Epilepsia Open access 14 Apr 2026 1
17 Closing the Gap to Interventions for Tuberous Sclerosis Complex–Associated Neuropsychiatric Disorders (TAND): Protocol for a Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2) Petrus J. de Vries et al. · JMIR Research Protocols Open access 17 Mar 2026 1
18 Clinical Center for Adults With Neurodevelopmental Disorders S.W. Cole, Kari Luther Rosbeck, Steven L. Roberds et al. · Neurology 30 Sep 2025 1
19 Cutaneous manifestations-associated with tuberous sclerosis complex and the use of topical rapamycin in the United States: a sub-analysis of an international survey of caregivers and patients Sreedevi Boggarapu, Gabrielle V. Rushing, Ashley J. Pounders et al. · Orphanet Journal of Rare Diseases Open access 25 Aug 2025 1
20 Impact of Prolonged Seizures on Patients’ and Caregivers’ Quality of Life (P1-9.014) Danya Kaye, Michelle Manzo, Andrea L. Wilkinson et al. · Neurology 7 Apr 2025 1
21 Circulating biomarkers of kidney angiomyolipoma and cysts in tuberous sclerosis complex patients Varvara I. Rubtsova, Yujin Chun, Joo‐Hwan Kim et al. · iScience Open access 13 Jun 2024 1
22 Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry Together Lisa Moore-Ramdin, Agnies M. van Eeghen, Joanne Stevens et al. · Patient Open access 11 Jul 2026 0
23 Does seizure duration matter? A quantitative and qualitative study on the burden and unmet needs of prolonged seizures in people living with epilepsy and their caregivers Danya Kaye, Rebecca H. Burns, Cédric Laloyaux et al. · Epilepsy & Behavior Open access 27 Jan 2026 0
24 Disease Burden and Associated Factors in Chinese Patients with Tuberous Sclerosis Complex: Results of a Patient and Caregiver Survey Fangping Wang, Luyang Zhang, Jianxiang Liao et al. · International Journal of General Medicine Open access Mar 2025 0
25 Caregiver-reported Nonseizure Outcomes with Real-world Use of Cannabidiol (CBD) in Tuberous Sclerosis Complex (TSC): Interim Results from the BECOME-TSC Survey (P8-1.010) Sarah Wilson, Mary Kay Koenig, Debopam Samanta et al. · Neurology 9 Apr 2024 0
26 Caregiver-reported Seizure Outcomes with Real-world Use of Cannabidiol (CBD) in Tuberous Sclerosis Complex (TSC): Interim Results From the BECOME-TSC Survey (P8-1.005) Mary Kay Koenig, Sarah J. Wilson, Debopam Samanta et al. · Neurology 9 Apr 2024 0
27 Circulating biomarkers of kidney tumors in TSC (tuberous sclerosis complex) patients Varvara I. Rubtsova, Yujin Chun, Joo‐Hwan Kim et al. · medRxiv PreprintOpen access Apr 2024 0
28 Family reflections: tuberous sclerosis complex (TSC) Shelly Meitzler · Pediatric Research 11 Sep 2020 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.